Airbus initiates partial stock repurchasing to bolster employee share-ownership schemes and further equity remuneration initiatives.
Airbus, the European aerospace giant, has announced the commencement of a share buyback programme on September 8, 2025. The programme, authorised by shareholders, aims to avoid dilution of existing shareholders and support future employee share ownership plan activities and equity-based compensation plans.
The first tranche of this programme will be managed by investment firm JPMorgan and will run from September 8, 2025, to no later than October 31, 2025. The first tranche will comprise up to 2,070,000 shares. The maximum number of shares that can be bought back under the entire programme is 4,140,000.
The buyback programme is subject to market conditions and applicable rules and regulations, including the EU Market Abuse Regulation and its Commission Delegated Regulation. The maximum monetary amount for the buyback programme will be determined by the price of the shares at the time of purchase.
It is important to note that the investment firm making purchases for the buyback programme will do so independently of Airbus. The purchases for the buyback programme do not constitute an offer to sell securities or a solicitation to buy or subscribe for any securities.
The information in this announcement is for background purposes only and is not intended as investment advice or a recommendation to transact in any security. The information contained in this announcement is not full or complete. No reliance may be placed on the information contained in this announcement or its accuracy or completeness.
The programme will end on January 16, 2026. The detailed information on the Airbus share buyback programme can be found on the Airbus website at: https://www.our-website/en/investors/share-price-and-information#buyback.
This announcement is not intended for use in any jurisdiction where its publication or distribution would be prohibited or restricted by applicable law or regulation. The information in this announcement is subject to change.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant
